Home › Funds › TCG Crossover Management, LLC › AMLX
TCG Crossover Management, LLC position in AMLX
AMYLYX PHARMACEUTICALS INC · Health Care
TCG Crossover Management, LLC reported holding 6,243,812 shares of AMLX (AMYLYX PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$112.1M, representing 2.70% of its reported portfolio and ranking #10 among its reported holdings. TCG Crossover Management, LLC has disclosed AMLX holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How TCG Crossover Management, LLC's AMLX position evolved
TCG Crossover Management, LLC first disclosed a stake in AMLX in Q3 2024 at 4,643,812 shares (US$15.0M). The position peaked in Q2 2026 at 6,243,812 shares, worth US$112.1M. Across 8 filings, TCG Crossover Management, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 6,243,812 shares valued at US$112.1M. Notable position changes include a 28% increase in Q1 2025 (shares rose 81% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 4.64M | $15.05M | New |
| Q4 2024 | 4.64M | $17.55M | Hold |
| Q1 2025 | 5.94M | $21.04M | Add |
| Q2 2025 | 5.94M | $38.10M | Hold |
| Q3 2025 | 6.24M | $84.85M | Add |
| Q4 2025 | 6.24M | $75.43M | Hold |
| Q1 2026 | 6.24M | $86.79M | Hold |
| Q2 2026 | 6.24M | $112.14M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AMLX and 13F data
AMLX (AMYLYX PHARMACEUTICALS INC) is a Health Care company. 50 other funds we track also report a position in AMLX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$149.7M), Commodore Capital LP (US$101.5M), Saturn V Capital Management LP (US$83.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AMLX
- PERCEPTIVE ADVISORS LLC 8.33M sh · $149.69M · Q2 2026
- Commodore Capital LP 5.65M sh · $101.47M · Q2 2026
- Saturn V Capital Management LP 4.62M sh · $83.05M · Q2 2026
- First Light Asset Management, LLC 3.02M sh · $54.30M · Q2 2026
- Siren, L.L.C. 1.48M sh · $26.59M · Q2 2026
- Almitas Capital LLC 974.88K sh · $17.51M · Q2 2026
- Jones Hill Capital LP 894.06K sh · $16.06M · Q2 2026
- Boxer Capital Management, LLC 800.00K sh · $14.37M · Q2 2026
- GREAT POINT PARTNERS LLC 700.00K sh · $12.57M · Q2 2026
- Parkman Healthcare Partners LLC 398.78K sh · $7.16M · Q2 2026
- HighVista Strategies LLC 386.08K sh · $6.93M · Q2 2026
- STEMPOINT CAPITAL LP 384.30K sh · $6.90M · Q2 2026
More on TCG Crossover Management, LLC
FAQ
How long has TCG Crossover Management, LLC held AMLX?
TCG Crossover Management, LLC has disclosed AMLX holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
What is TCG Crossover Management, LLC's current position in AMLX?
As of Q2 2026, TCG Crossover Management, LLC holds 6.24M shares of AMLX (AMYLYX PHARMACEUTICALS INC), valued at $112.14M, representing 2.70% of its reported portfolio and ranking #10.
Has TCG Crossover Management, LLC been buying or selling AMLX?
In the latest 13F filing (Q2 2026), TCG Crossover Management, LLC held unchanged its position in AMLX. The position peaked in Q2 2026 at 6.24M shares.
Which other funds hold AMLX?
Other major institutional holders of AMLX include PERCEPTIVE ADVISORS LLC, Commodore Capital LP, Saturn V Capital Management LP, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.